Login to Your Account



CAT, Abbott Settle Humira Dispute: Abbott Pays $255M

By Karen Pihl-Carey


Wednesday, November 2, 2005
Ending a 2-year-old dispute, Cambridge Antibody Technology plc and Abbott Laboratories reached an agreement concerning Humira royalties payable to CAT under a 1995 deal. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription